Publications by authors named "Chaolong Lin"

Claim this Profile
B
Benchmarking the CoW with the TopCoW Challenge: Topology-Aware Anatomical Segmentation of the Circle of Willis for CTA and MRA.
Kaiyuan Yang, Fabio Musio, Yihui Ma, Norman Juchler, Johannes C Paetzold, Huilin Zhao, James Hallinan, Chaolong Lin, Zehang Lin

ArXiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T-cell Activity in Hepatocellular Carcinoma.
Yating Chang, Naizhen Wang, Shaopeng Li, Jiaqi Zhang, Yipeng Rao, Yanhua Lin, Chaolong Lin

Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscape and response to oncolytic virus-based immunotherapy.
Chaolong Lin, Wenzhong Teng, Yang Tian, Shaopeng Li, Ningshao Xia

Front Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1.
Wenfeng Ren, Zilong Xu, Yating Chang, Fei Ju, Hongning Wu, Yanhua Lin, Chaolong Lin

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
Fei Ju, Yong Luo, Chaolong Lin, Xian Jia, Zilong Xu, Yanhua Lin

J Immunother Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D.
Rui Tian, Fei Ju, Mengqin Yu, Zhiqi Liang, Zilong Xu, Yanhua Lin, Chaolong Lin

Antiviral Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens.
Yong Luo, Chaolong Lin, Yidi Zou, Fei Ju, Wenfeng Ren, Yanhua Lin, Huiling Liu

Oncoimmunology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade.
Chaolong Lin, Wenfeng Ren, Yong Luo, Shaopeng Li, Yating Chang

Cancer Immunol Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous Injections of a Rationally Selected Oncolytic Herpes Virus as a Potent Virotherapy for Hepatocellular Carcinoma.
Yong Luo, Chaolong Lin, Wenfeng Ren, Fei Ju, Zilong Xu, Huiling Liu

Mol Ther Oncolytics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach for rapid high-throughput selection of recombinant functional rat monoclonal antibodies.
Qin Chen, Shengping Qiu, Huanhuan Li, Chaolong Lin, Yong Luo

BMC Immunol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
Chaolong Lin, Huanhuan Li, Mengru Hao, Dan Xiong, Yong Luo

Sci Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Yong Luo, Dan Xiong, Huan-Huan Li, Sheng-Ping Qiu, Chao-Long Lin

Virol J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis